CIK 0000025743 · Non-accelerated filer<br>Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 870233535
- Phone
- 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-18 | Walker Marlan D Chief Executive Officer | Option exercise · Restricted Stock Units | −2,311 | 0 | ||
| 2025-02-18 | Walker Marlan D Chief Executive Officer | Option exercise · Restricted Stock Units | −770 | 0 | ||
| 2025-02-18 | Walker Marlan D Chief Executive Officer | Option exercise · Restricted Stock Units | −1,733 | 1,733 | ||
| 2024-08-22 | Collins Cooper C. Director | Purchase | +4,094 | $1.73 | $7K | 52,016 |
| 2024-08-21 | Collins Cooper C. Director | Purchase | +1,200 | $1.70 | $2K | 47,922 |
| 2023-12-07 | Walker Marlan D Chief Executive Officer | Sale | −4,550 | $2.24 | $10K | 62,565 |
| 2023-12-06 | Walker Marlan D Chief Executive Officer | Sale | −14,500 | $2.31 | $33K | 67,115 |
| 2023-12-05 | Walker Marlan D Chief Executive Officer | Option exercise | +70,000 | 81,615 | ||
| 2023-12-05 | Walker Marlan D Chief Executive Officer | Option exercise · Restricted Stock Units | −70,000 | 0 | ||
| 2023-11-15 | Rubric Capital Management LP Director | Grant or award | +877,192 | $2.28 | $2.0M | 2,946,908 |
| 2023-08-17 | ZIEGLER JOSEPH Principal Financial Officer | Grant or award | +7,500 | 7,500 | ||
| 2023-07-17 | Thompson Tommy G Director | Grant or award · Restricted Stock Units | +8,500 | 8,500 | ||
| 2023-07-17 | Naughton Gail K Director | Grant or award · Restricted Stock Unit | +8,500 | 8,500 | ||
| 2023-07-17 | Collins Cooper C. Director | Grant or award · Restricted Stock Units | +8,500 | 8,500 | ||
| 2023-06-28 | Rubric Capital Management LP Director | Grant or award | +312,525 | $3.68 | $1.1M | 2,069,716 |
| 2023-04-26 | Walker Marlan D Chief Executive Officer | Option exercise | +1,010 | 14,041 | ||
| 2023-04-26 | Walker Marlan D Chief Executive Officer | Option exercise | +1,734 | 12,307 | ||
| 2023-04-26 | Walker Marlan D Chief Executive Officer | Sale | −692 | $3.64 | $3K | 11,615 |
| 2023-04-26 | Walker Marlan D Chief Executive Officer | Option exercise · Restricted Stock Units | −1,010 | 0 | ||
| 2023-04-26 | Walker Marlan D Chief Executive Officer | Option exercise · Restricted Stock Units | −1,734 | 3,466 |
Page 2 of 11 · 206 trades